Alvogen Ipco S.a.r.l. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Alvogen Ipco S.a.r.l.

Patent Number:
Title:
Dosing Regimen For Multiple Sclerosis
Opposition Date:
Apr 11, 2019
Patent Number:
Title:
Low Frequency Glatiramer Acetate Therapy
Opposition Date:
Mar 27, 2019
Patent Number:
Title:
Low Frequency Glatiramer Acetate Therapy
Opposition Date:
Oct 4, 2017

Want to track Alvogen Ipco S.a.r.l.?

Feel free to send us a message here and we will get back to you